A Stepwise Approach to the
Interpretation of Pulmonary
Function Tests
Dr Suman Roy
PGT
Why PFTs?
• Dx of Symtomatic Ds
• Screening of Early Asymtomatic Ds
• Prognostication of Known Ds
• Monitoring Response to Known Ds
Purpose of PFTs ?
As a dx tool it helps to classify LD into 1 of 3 broad categories
Obstructive Lung Disease Restrictive Lung Disease PulmonaryVascular Disease
COPD
(Chr. Bronchitis< ->Emphysema)
Asthma
Bronchitis
Cystic Fibrosis
ILD
( Pul Fibrosis, Sarcoidosis)
Chest Wall Pathology
( Kyphosis, Scoliosis)
Obesity
Neuromascular Disease
( ALS, Mascular Dystrophy)
Pr Pul HTN
Chr Thromboembolic Ds
These categories are not mutually exclusive :
COPD can be Obstructive + Vascular
Sarcoidosis can be Restrictive + Obstructive + Vascular
Function of Pulmonary System Tested by PFTs
• Airways
Large & Small Airways
• Parenchyma
Alveoli
Interstitium
• Pulmonary Vasculature
• Bellows/Pump Mechanism
Diaphragm
Chest Wall
• Neural Control of Ventilation
How Spirometry is performed?
FEV1
Values Measured by Spirometry
Major Minor
FEV1
FVC
FEV1/FVC
Flow Volume Loop
Peek Expiratory Flow Rate
(PEFR)
PEF (25-75)
Maximum Voluntary Ventilation
Response to Bronchdilators
Interpretation of FEV1, FVC
& FEV1/FVC Ratio
FEV1 FVC FEV1 / FVC Ratio
( Tiffeneau Index)
Obstructive Lung
Disease
Normal
Very mild obstruction
or Decreased
Mod / Severe
Obstruction
Normal
Mild / Moderate
obstruction
Decreased
Severe obstruction
Decreased
< 70%
Restrictive Lung
Disease
Normal
or Decreased
Decreased Normal
or Increased
70 % or More
Interpretation of Spirometry
Assess Low Assess Normal/High Assess
FVC FEV1/FVC FVC
LOW Normal Low Normal
Obstruction Obstruction Possible Normal Lung
Or Mixed Restriction Mechanics
Where is Pulmonary Vascular Disease ?
Staging of COPD Based on FEV1
The Global initiative for Chronic Obstructive Lung Disease
(GOLD) classifies COPD severity based on post-bronchodilator FEV1
FEV1 compared to predicted for Age/gender/height
GOLD Stage I FEV1 _> 80%
GOLD Stage I I 50% _< FEV1 _< 80%
GOLD Stage I I I 30% _< FEV1 _> 50%
GOLD Stage I V FEV1 _< 30%
FEV1/FVC < 0.7 There is weak co-relation between FEV1 & Quality of Life
GOLD Criteria for Severity of Airflow Obstruction in COPD
GOLD Stage Severity Spirometry
• I Mild FEV1/FVC <0.7
FEV1 ≥80% predicted
• II Moderate FEV1/FVC <0.7
FEV1 ≥50% but <80% predicted
• III Severe FEV1/FVC <0.7
FEV1 ≥30% but <50% predicted
• IV Very severe FEV1/FVC <0.7
FEV1 <30% predicted
Interpretation of Pulmonary Function Test
Interpretation of Pulmonary Function Test
Interpretation of Pulmonary Function Test
Interpretation of Pulmonary Function Test
Interpretation of Pulmonary Function Test
Interpretation of Pulmonary Function Test
Interpretation of Pulmonary Function Test
Interpretation of Pulmonary Function Test
Interpretation of Pulmonary Function Test
Interpretation of Pulmonary Function Test
Interpretation of Pulmonary Function Test
Interpretation of Pulmonary Function Test
Interpretation of Pulmonary Function Test
Interpretation of Pulmonary Function Test
Interpretation of Pulmonary Function Test
Interpretation of Pulmonary Function Test
Interpretation of Pulmonary Function Test
Interpretation of Pulmonary Function Test
Interpretation of Pulmonary Function Test
Interpretation of Pulmonary Function Test

Interpretation of Pulmonary Function Test

  • 1.
    A Stepwise Approachto the Interpretation of Pulmonary Function Tests Dr Suman Roy PGT
  • 6.
    Why PFTs? • Dxof Symtomatic Ds • Screening of Early Asymtomatic Ds • Prognostication of Known Ds • Monitoring Response to Known Ds
  • 7.
    Purpose of PFTs? As a dx tool it helps to classify LD into 1 of 3 broad categories Obstructive Lung Disease Restrictive Lung Disease PulmonaryVascular Disease COPD (Chr. Bronchitis< ->Emphysema) Asthma Bronchitis Cystic Fibrosis ILD ( Pul Fibrosis, Sarcoidosis) Chest Wall Pathology ( Kyphosis, Scoliosis) Obesity Neuromascular Disease ( ALS, Mascular Dystrophy) Pr Pul HTN Chr Thromboembolic Ds These categories are not mutually exclusive : COPD can be Obstructive + Vascular Sarcoidosis can be Restrictive + Obstructive + Vascular
  • 8.
    Function of PulmonarySystem Tested by PFTs • Airways Large & Small Airways • Parenchyma Alveoli Interstitium • Pulmonary Vasculature • Bellows/Pump Mechanism Diaphragm Chest Wall • Neural Control of Ventilation
  • 14.
  • 16.
  • 20.
    Values Measured bySpirometry Major Minor FEV1 FVC FEV1/FVC Flow Volume Loop Peek Expiratory Flow Rate (PEFR) PEF (25-75) Maximum Voluntary Ventilation Response to Bronchdilators
  • 21.
    Interpretation of FEV1,FVC & FEV1/FVC Ratio FEV1 FVC FEV1 / FVC Ratio ( Tiffeneau Index) Obstructive Lung Disease Normal Very mild obstruction or Decreased Mod / Severe Obstruction Normal Mild / Moderate obstruction Decreased Severe obstruction Decreased < 70% Restrictive Lung Disease Normal or Decreased Decreased Normal or Increased 70 % or More
  • 22.
    Interpretation of Spirometry AssessLow Assess Normal/High Assess FVC FEV1/FVC FVC LOW Normal Low Normal Obstruction Obstruction Possible Normal Lung Or Mixed Restriction Mechanics Where is Pulmonary Vascular Disease ?
  • 40.
    Staging of COPDBased on FEV1 The Global initiative for Chronic Obstructive Lung Disease (GOLD) classifies COPD severity based on post-bronchodilator FEV1 FEV1 compared to predicted for Age/gender/height GOLD Stage I FEV1 _> 80% GOLD Stage I I 50% _< FEV1 _< 80% GOLD Stage I I I 30% _< FEV1 _> 50% GOLD Stage I V FEV1 _< 30% FEV1/FVC < 0.7 There is weak co-relation between FEV1 & Quality of Life
  • 41.
    GOLD Criteria forSeverity of Airflow Obstruction in COPD GOLD Stage Severity Spirometry • I Mild FEV1/FVC <0.7 FEV1 ≥80% predicted • II Moderate FEV1/FVC <0.7 FEV1 ≥50% but <80% predicted • III Severe FEV1/FVC <0.7 FEV1 ≥30% but <50% predicted • IV Very severe FEV1/FVC <0.7 FEV1 <30% predicted